Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1964 Dec;52(6):1419–1426. doi: 10.1073/pnas.52.6.1419

RESCUE OF DRUG-REQUIRING AND DRUG-INHIBITED ENTEROVIRUSES*

Nobuko Ikegami 1,, Hans J Eggers 1, Igor Tamm 1
PMCID: PMC300462  PMID: 14243514

Full text

PDF
1419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALTIMORE D., EGGERS H. J., FRANKLIN R. M., TAMM I. Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production. Proc Natl Acad Sci U S A. 1963 Jun;49:843–849. doi: 10.1073/pnas.49.6.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BALTIMORE D., FRANKLIN R. M. A NEW RIBONUCLEIC ACID POLYMERASE APPEARING AFTER MENGOVIRUS INFECTION OF L-CELLS. J Biol Chem. 1963 Oct;238:3395–3400. [PubMed] [Google Scholar]
  3. CORDS C. E., HOLLAND J. J. REPLICATION OF POLIOVIRUS RNA INDUCED BY HETEROLOGOUS VIRUS. Proc Natl Acad Sci U S A. 1964 Jun;51:1080–1082. doi: 10.1073/pnas.51.6.1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. EAGLE H. Amino acid metabolism in mammalian cell cultures. Science. 1959 Aug 21;130(3373):432–437. doi: 10.1126/science.130.3373.432. [DOI] [PubMed] [Google Scholar]
  6. EGGERS H. J., REICH E., TAMM I. THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES. Proc Natl Acad Sci U S A. 1963 Aug;50:183–190. doi: 10.1073/pnas.50.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. EGGERS H. J., TAMM I. Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med. 1961 Apr 1;113:657–682. doi: 10.1084/jem.113.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HALPEREN S., EGGERS H. J., TAMM I. EVIDENCE FOR UNCOUPLED SYNTHESIS OF VIRAL RNA AND VIRAL CAPSIDS. Virology. 1964 Sep;24:36–46. doi: 10.1016/0042-6822(64)90145-x. [DOI] [PubMed] [Google Scholar]
  9. HANAFUSA H., HANAFUSA T., RUBIN H. ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS. Proc Natl Acad Sci U S A. 1964 Jan;51:41–48. doi: 10.1073/pnas.51.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HOLLAND J. J., CORDS C. E. MATURATION OF POLIOVIRUS RNA WITH CAPSID PROTEIN CODED BY HETEROLOGOUS ENTEROVIRUSES. Proc Natl Acad Sci U S A. 1964 Jun;51:1082–1085. doi: 10.1073/pnas.51.6.1082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HOLLAND J. J. Depression of host-controlled RNA synthesis in human cells during poliovirus infection. Proc Natl Acad Sci U S A. 1963 Jan 15;49:23–28. doi: 10.1073/pnas.49.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HOLLAND J. J., HOYER B. H., McLAREN L. C., SYVERTON J. T. Enteroviral ribonucleic acid. I. Recovery from virus and assimilation by cells. J Exp Med. 1960 Nov 1;112:821–839. doi: 10.1084/jem.112.5.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LEDINKO N. Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology. 1963 May;20:107–119. doi: 10.1016/0042-6822(63)90145-4. [DOI] [PubMed] [Google Scholar]
  14. LODDO B., FERRARI W., SPANEDDA A., BROTZU G. In vitro guanidino-resistance and guanidino-dependence of poliovirus. Experientia. 1962 Nov 15;18:518–519. doi: 10.1007/BF02151608. [DOI] [PubMed] [Google Scholar]
  15. LWOFF A., KOCH A., LWOFF M. [On the development of a poliovirus mutant requiring guanidine]. C R Hebd Seances Acad Sci. 1963 Jun 10;256:5228–5231. [PubMed] [Google Scholar]
  16. MELNICK J. L., CROWTHER D., BARRERA-ORO J. Rapid development of drug-resistant mutants of poliovirus. Science. 1961 Aug 25;134(3478):557–557. doi: 10.1126/science.134.3478.557. [DOI] [PubMed] [Google Scholar]
  17. TAMM I., EGGERS H. J. Differences in the selective virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine HCl. Virology. 1962 Nov;18:439–447. doi: 10.1016/0042-6822(62)90034-x. [DOI] [PubMed] [Google Scholar]
  18. VALENTINE R. C., ENGELHARDT D. L., ZINDER N. D. HOST-DEPENDENT MUTANTS OF THE BACTERIOPHAGE F2. II. RESCUE AND COMPLEMENTATION OF MUTANTS. Virology. 1964 Jun;23:159–163. doi: 10.1016/0042-6822(64)90278-8. [DOI] [PubMed] [Google Scholar]
  19. WECKER E., LEDERHILGER G. CURTAILMENT OF THE LATENT PERIOD BY DOUBLE-INFECTION WITH POLIOVIRUSES. Proc Natl Acad Sci U S A. 1964 Aug;52:246–251. doi: 10.1073/pnas.52.2.246. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES